Editorial: Improving cancer chemotherapy through pharmacogenomics: A research topic

dc.creatorQuiñones Sepúlveda, Luis
dc.creatorLee, Kuen S.
dc.date.accessioned2019-01-29T14:48:42Z
dc.date.available2019-01-29T14:48:42Z
dc.date.created2019-01-29T14:48:42Z
dc.date.issued2015
dc.identifierFrontiers in Genetics, Volumen 6, Issue JUN, 2018,
dc.identifier16648021
dc.identifier10.3389/fgene.2015.00195
dc.identifierhttps://repositorio.uchile.cl/handle/2250/160772
dc.languageen
dc.publisherFrontiers Research Foundation
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceFrontiers in Genetics
dc.subjectAntineoplastic agents
dc.subjectGenetic
dc.subjectOncology
dc.subjectPharmacogenetics
dc.subjectPharmacogenomics
dc.subjectPolymorphism
dc.titleEditorial: Improving cancer chemotherapy through pharmacogenomics: A research topic
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución